ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AIM ImmunoTech Inc

AIM ImmunoTech Inc (HXB2)

0.226
0.006
( 2.73% )
Updated: 01:03:00
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.226
Bid
0.218
Ask
0.23
Volume
3,000
0.226 Day's Range 0.226
0.178 52 Week Range 0.60
Previous Close
0.22
Open
0.226
Last Trade
3000
@
0.226
Last Trade Time
01:02:58
Average Volume (3m)
7,984
Financial Volume
-
VWAP
-

HXB2 Latest News

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Preliminary finding of stable disease in two...

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE...

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”...

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Next safety cohort...

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer OCALA...

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Year marked by growing body of promising data demonstrating Ampligen’s potential to...

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM...

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research Data demonstrate...

AIM ImmunoTech Announces Launch of CEO Corner Platform

AIM ImmunoTech Announces Launch of CEO Corner Platform CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested...

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update

AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update Company continues progress across Ampligen® clinical development programs Growing...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.029.708737864080.2060.2260.213850.21256331DE
4-0.02-8.130081300810.2460.2460.17887490.20729914DE
12-0.0559999-19.85812760930.28199990.310.17879840.23531086DE
26-0.13-36.51685393260.3560.4360.17850840.25695784DE
52-0.22-49.32735426010.4460.60.17839840.32737932DE
156-0.3389999-59.99999292040.56499990.610.17839320.34623229DE
260-0.3389999-59.99999292040.56499990.610.17839320.34623229DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AA3Vortex Energy Corp
0.049 €
(38.03%)
33.5k
1UR1Bee Vectoring Technologies International Inc
0.0075 €
(36.36%)
10k
TLIKArzneiwerk AG VIDA
0.88 €
(27.54%)
83
02GGuangzhou Automobile Group
0.4502 €
(27.32%)
16.93k
DGDGrey Mining Ltd
1.19 €
(27.16%)
51.69k
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
6k
ZM7AFuelPositive Corp
0.0165 €
(-34.00%)
8.89k
C0MCCS Abwicklungs AG
0.092 €
(-31.14%)
19.82k
G6D2Surge Copper Corp
0.045 €
(-28.34%)
40.86k
47GAGo Metals Corp
0.022 €
(-27.63%)
3.4k
PUBPancontinental Energy NL
0.015 €
(15.38%)
540k
VJFVital Metals Ltd
0.0015 €
(-25.00%)
510k
AXIAtos SE
0.8508 €
(5.04%)
464.24k
L2QLatrobe Magnesium Ltd
0.0163 €
(-0.61%)
391.98k
0XPArgo Blockchain Plc
0.076 €
(-24.30%)
353.17k

Discussion

View Full Feed
boogeyman6757565 boogeyman6757565 2 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz4SJKAZ/call-on-blockchain-support-number-need-helpline-number?language=en_US📲
QueenMinotaur95 QueenMinotaur95 2 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Ryx2nKAB/contact-17076097626-how-do-i-contact-blockchain-support-number-easy-guide?language=en_US

https://community.geotab.com/s/question/0D5Pd00000RyxsLKAR/247-%F0%9D%95%83%F0%9D%95%9A%F0%9D%95%A7%F0%9D%95%96-support-how-do-i-contact-
Real McCoy Real McCoy 4 minutes ago
No one is interested in your shares. At all. They’re dead.
Real McCoy Real McCoy 4 minutes ago
Just trying to get to the end man.
Viking61 Viking61 7 minutes ago
Arnold has been saying the same all the way up from .40.
FNMA
knrorrel knrorrel 15 minutes ago
$QBTS the week is already starting nice and green in Germany. Let's see where it goes this week...... Quantum and ai the new shares of the future with enormous potential, imho
https://www.ariva.de/aktien/d-wave-quantum-systems-inc-aktie/kurse/handelsplaetze



QBTS
knrorrel knrorrel 15 minutes ago
$QBTS the week is already starting nice and green in Germany. Let's see where it goes this week...... Quantum and ai the new shares of the future with enormous potential, imho
https://www.ariva.de/aktien/d-wave-quantum-systems-inc-aktie/kurse/handelsplaetze

QBTS
AlwaysOptimistic AlwaysOptimistic 18 minutes ago
Great find GE. Hopefully, he can Make NioCorp Great Again!
NB
boogeyman6757565 boogeyman6757565 21 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
Krombacher Krombacher 21 minutes ago
SSC’s Endless Negativity: Let’s Address the Facts

1. Stock Performance
Yes, ERHC’s stock has declined over the years, but your constant harping on the historical decline ignores the nuance of long-term investment strategies. My positions have always been based on logical specul
ERHE
skeptical G skeptical G 24 minutes ago
was hoping for a Ravens win
IGPK
bbotcs bbotcs 29 minutes ago
Biden pardoned Hunter. Said he wouldn't, but we knew he would and he did. Who is going to pardon Joe?
bbotcs bbotcs 31 minutes ago
lj: SMCI
Bought shares at $35 and change last week. If the company survives, the purchase price will be a bargain in a year or so.
SMCI
Nrdc92 Nrdc92 31 minutes ago
That's how these cults work, Dan. The members are systematically groomed and then brainwashed, the result of which is to be unable to process facts outside the cult dogma. Here, it's even worse because the cult members have a financial stake in the cult, which provides additional incentive to remain
LWLG
nowwhat2 nowwhat2 33 minutes ago
Wooo-wooo !

https://investorshub.advfn.com/uimage/uploads/2024/12/2/evqdeLTC_111111_27_30d_chan.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/2/qrlzkltc_111111_30_30d_1pm_TL_W.jpg




https://investo
LTCUSD
Fdc4 Fdc4 43 minutes ago
I would believe such from anything else but from HMBL. This is a ponzi mate, down it goes, no escape to nobody. Careful, CEO watching for more dilution space expansion
HMBL
Fdc4 Fdc4 46 minutes ago
No FINRA or audit financials, I doubt this will see $0.006 again. Forget about $0.009, this is going down to trips
IGPK
Fdc4 Fdc4 48 minutes ago
Now your are talking about your beliefs. Did you know your beliefs aren’t aligned with the real facts? If you want others to mind their business, keep your nonsense to yourself mate. Nobody want to hear a pumper that doesn’t have idea of what he is talking about. Chill kid
IGPK
Biotechotcguy Biotechotcguy 48 minutes ago
Don't bet against the Jews. I'm in this till the end. 
DROR
sunspotter sunspotter 49 minutes ago
Still howling at the moon, chazzy?

Time to admit that both HDVY and VPLM are both insider enrichment scams masquerading as wannabe patent trolls.
HDVY VPLM
Fdc4 Fdc4 52 minutes ago
Good points Orca, well put
VDRM
BDEZ BDEZ 1 hour ago
No more income tax, Tariffs only. Do it
gitreal gitreal 1 hour ago
All that is a waste of time. You assume the assets are worth what they say they are. With no audit and all the other shady/sketchy stuff going on, probably should assume the assets are worthless.
BMXI
BDEZ BDEZ 1 hour ago
The real reason for the pardon

Biden,who will not even meet with his grand daughter Navy, didn’t pardon his son because he’s a good father. He did so because, as his son admits on the Hard Drive, for 30 years Hunter has given half the millions he’s collected to the Boss of the Crime F

Your Recent History

Delayed Upgrade Clock